Hundsberger, Thomas

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 19.

Journal Article

Mastall, Maximilian; Roth, Patrick; Bink, Andrea; Fischer Maranta, Angela; Läubli, Heinz; Hottinger, Andreas Felix; Hundsberger, Thomas; Migliorini, Denis; Ochsenbein, Adrian; Seystahl, Katharina; Imbach, Lukas; Hortobagyi, Tibor; Held, Leonhard; Weller, Michael; Wirsching, Hans-Georg (2024). A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol. BMC cancer, 24(1) BioMed Central 10.1186/s12885-023-11797-z

Ripellino, Paolo; Lascano, Agustina Maria; Scheidegger, Olivier; Schilg-Hafer, Lenka; Schreiner, Bettina; Tsouni, Pinelopi; Vicino, Alex; Peyer, Anne-Kathrin; Humm, Andrea Maria; Décard, Bernhard; Pianezzi, Enea; Zezza, Giulia; Sparasci, Davide; Hundsberger, Thomas; Dietmann, Anelia; Jung, Hans; Kuntzer, Thierry; Wilder-Smith, Einar; Martinetti-Lucchini, Gladys; Petrini, Orlando; ... (2024). Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study. European journal of neurology, 31(1), e16030. Wiley 10.1111/ene.16030

Filippidis, Paraskevas; Damas, Jose; Viala, Benjamin; Assal, Frederic; Tshikung, Olivier Nawej; Tarr, Philip; Derfuss, Tobias; Oberholzer, Michael; Jelcic, Ilijas; Hundsberger, Thomas; Sacco, Leonardo; Cavassini, Matthias; Du Pasquier, Renaud; Darling, Katharine E A (2023). Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study. Journal of acquired immune deficiency syndromes, 93(3), pp. 219-228. Wolters Kluwer Health 10.1097/QAI.0000000000003189

Joerger, Markus; Hundsberger, Thomas; Haefliger, Simon; von Moos, Roger; Hottinger, Andreas F; Kaindl, Thomas; Engelhardt, Marc; Marszewska, Michalina; Lane, Heidi; Roth, Patrick; Stathis, Anastasios (2023). Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study. Investigational new drugs, 41(2), pp. 267-275. Springer 10.1007/s10637-023-01336-9

Fischer, Galina Farina; Brügge, Detlef; Andratschke, Nicolaus; Baumert, Brigitta Gertrud; Bosetti, Davide Giovanni; Caparrotti, Francesca; Herrmann, Evelyn; Papachristofilou, Alexandros; Rogers, Susanne; Schwyzer, Lucia; Zwahlen, Daniel Rudolf; Hundsberger, Thomas; Putora, Paul Martin (2022). Postoperative radiotherapy for meningiomas - a decision-making analysis. BMC cancer, 22(1), p. 492. BioMed Central 10.1186/s12885-022-09607-z

Dietmann, Anelia; Ripellino, Paolo; Humm, Andrea M.; Hundsberger, Thomas; Schreiner, Bettina; Théaudin, Marie; Scheidegger, Olivier (2022). Hot Topics on COVID-19 and Its Possible Association with Guillain-Barré Syndrome. Clinical and translational neuroscience, 6(1), p. 7. MDPI 10.3390/ctn6010007

Damas, José; Ledergerber, Bruno; Nadin, Isaure; Tarr, Philip E; Stoeckle, Marcel; Kunze, Ursi; Hauser, Christoph; Gutbrod, Klemens; Calmy, Alexandra; Assal, Frédéric; Schmid, Patrick; Hundsberger, Thomas; di Benedetto, Caroline; Rossi, Stefania; Hasse, Barbara; Schlosser, Ladina; Pasquier, Renaud du; Darling, Katharine E A; Cavassini, Matthias (2021). Neurocognitive course at two-year follow-up in the neurocognitive assessment in the metabolic and aging cohort (NAMACO) study. AIDS, 35(15), pp. 2469-2480. Wolters Kluwer Health 10.1097/QAD.0000000000003057

Hofer, Silvia; Keller, Kristina; Imbach, Lukas; Roelcke, Ulrich; Hutter, Gregor; Hundsberger, Thomas; Hertler, Caroline; Le Rhun, Emilie; Vasella, Flavio; Cordier, Dominik; Neidert, Marian; Hottinger, Andreas; Migliorini, Denis; Pflugshaupt, Tobias; Eggenberger, Noemi; Baumert, Brigitta; Läubli, Heinz; Gramatzki, Dorothee; Reinert, Michael; Pesce, Gianfranco; ... (2021). Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM). Swiss medical weekly, 151, w20501. EMH Media 10.4414/smw.2021.20501

Wirsching, Hans-Georg; Roelcke, Ulrich; Weller, Jonathan; Hundsberger, Thomas; Hottinger, Andreas F; von Moos, Roger; Caparrotti, Francesca; Conen, Katrin; Remonda, Luca; Roth, Patrick; Ochsenbein, Adrian; Tabatabai, Ghazaleh; Weller, Michael (2021). MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial. Clinical cancer research, 27(1), pp. 179-188. American Association for Cancer Research 10.1158/1078-0432.CCR-20-2096

Roth, Patrick; Hottinger, Andreas F; Hundsberger, Thomas; Läubli, Heinz; Schucht, Philippe; Reinert, Michael; Mamot, Christoph; Roelcke, Ulrich; Pesce, Gianfranco; Hofer, Silvia; Weller, Michael (2020). A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults. Swiss medical weekly, 150(w20256), w20256. EMH Schweizerischer Ärzteverlag 10.4414/smw.2020.20256

Iseli, Thomas; Fischer, Galina Farina; Panje, Cédric; Glatzer, Markus; Hundsberger, Thomas; Rothermundt, Christian; Schmidt, Barbara; Sirén, Charlotta; Plasswilm, Ludwig; Putora, Paul Martin (2020). Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology - international journal of cancer research and treatment, 98(6), pp. 438-444. Karger 10.1159/000508132

Panje, Cédric; Putora, Paul M.; Hundsberger, Thomas; Hottinger, Andreas F; Roelcke, Ulrich; Pesce, Gianfranco; Herrmann, Evelyn; Matter-Walstra, Klazien (2019). Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss medical weekly, 149, w20153. EMH Media 10.4414/smw.2019.20153

Lagler, Florian B; Moder, Angelika; Rohrbach, Marianne; Hennermann, Julia; Mengel, Eugen; Gökce, Seyfullah; Hundsberger, Thomas; Rösler, Kai M.; Karabul, Nesrin; Huemer, Martina (2019). Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey. JIMD reports, 49(1), pp. 89-95. Wiley 10.1002/jmd2.12062

Hundsberger, Thomas; Schoser, Benedikt; Leupold, Daniela; Rösler, Kai Michael; Putora, Paul Martin (2019). Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale. Journal of neurology, 266(8), pp. 2010-2017. Springer-Medizin-Verlag 10.1007/s00415-019-09373-2

Scheidegger, Olivier; Leupold, Daniela; Sauter, Rafael; Findling, Oliver; Rösler, Kai Michael; Hundsberger, Thomas (2018). 36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry. Journal of neurology, 265(12), pp. 2783-2788. Springer-Medizin-Verlag 10.1007/s00415-018-9065-7

Panje, Cédric M; Glatzer, Markus; von Rappard, Joscha Stefan; Rothermundt, Christian; Hundsberger, Thomas; Zumstein, Valentin; Plasswilm, Ludwig; Putora, Paul Martin (2017). Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis. BMC Medical research methodology, 17(1), p. 123. BioMed Central 10.1186/s12874-017-0400-y

Putora, Paul; Panje, Cedric M; Papachristofilou, Alexandros; Dal Pra, Alan; Hundsberger, Thomas; Plasswilm, Ludwig (2014). Objective consensus from decision trees. Radiation oncology, 9(1), p. 270. BioMed Central 10.1186/s13014-014-0270-y

Hundsberger, Thomas; Rösler, Kai Michael; Findling, Oliver (2014). Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis. Journal of neurology, 261(9), pp. 1684-1690. Springer-Medizin-Verlag 10.1007/s00415-014-7402-z

Hundsberger, Thomas; Rohrbach, Marianne; Kern, Lukas; Rösler, Kai Michael (2013). Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease. Journal of neurology, 260(9), pp. 2279-2285. Springer-Medizin-Verlag 10.1007/s00415-013-6980-5

This list was generated on Wed Mar 27 16:20:47 2024 CET.
Provide Feedback